10% of the child population is said to have developmental disorders, making early intervention critical. Historically, appropriate diagnoses were difficult, resulting in societal maladjustment in children. In response, RICOH developed an advanced magnetoencephalography (MEG) system for infants. This leading-edge device enables a child’s brain to be scanned and diagnosed without distress.
RICOH is committed to early intervention in support of young patients. Their healthy future is especially important in an aging society facing a low birthrate. MEG is one innovation that demonstrates RICOH’s dedication to solving social challenges.
RICOH’s sensors go deeper into the brain. MEG combines sensing technology, high frequency measurements, and imaging technology to visualize the brain’s nerve activity. Minuscule fragments of magnetism generated by neural activity are painlessly measured with abundant functions available for analysis. RICOH provides support for both hardware and software to improve clinical diagnosis and research.
RICOH MEG Receives FDA 510(k) Clearance (USA)